Cargando…

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism

DESIGN: Retrospective cohort study. Patients. The data was obtained from a total of 87 PA patients treated with esaxerenone. The treatment group comprised 33 patients who received esaxerenone as first-line therapy and 54 patients that switched from another MRA to esaxerenone. Measurements. Blood pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujimoto, Masanori, Watanabe, Suzuka, Igarashi, Katsushi, Ruike, Yutaro, Ishiwata, Kazuki, Naito, Kumiko, Ishida, Akiko, Koshizaka, Masaya, Suzuki, Sawako, Shiko, Yuki, Koide, Hisashi, Yokote, Koutaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873463/ https://www.ncbi.nlm.nih.gov/pubmed/36704237 http://dx.doi.org/10.1155/2023/6453933

Ejemplares similares

Clinical Usefulness of the Growth Hormone–Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder
por: Suzuki, Sawako, et al.
Publicado: (2022)

LBODP006 Clinical Usefulness Of The Growth Hormone-releasing Peptide-2 Test For Hypothalamic-pituitary Disorder
por: Suzuki, Sawako, et al.
Publicado: (2022)

ODP301 Corticotroph Macroadenomas with Extensions to Third Ventricle: Four Case Reports
por: Suzuki, Yasuhiro, et al.
Publicado: (2022)

Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2020)

ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature Review
por: Naito, Kumiko, et al.
Publicado: (2021)

THU412 Role of Glucocorticoid On Bone Metabolism Through AKAP13
por: Igarashi, Katsushi, et al.
Publicado: (2023)

SUN-020 Analyses Of Clock Gene Expressions In Peripheral Leukocytes In Hypercortisolism
por: Ishiwata, Kazuki, et al.
Publicado: (2019)

Correction of Hypercortisolemia with an Improved Cognitive Function and Muscle Mass after Transsphenoidal Surgery in an Older Patient with Cushing's Disease
por: Terayama, Ryo, et al.
Publicado: (2022)

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020
por: Kato, Hisaya, et al.
Publicado: (2022)

A Case of a Pregnant Woman With Primary Aldosteronism and Superimposed Preeclampsia Treated With Esaxerenone
por: Yamashita, Kaoru, et al.
Publicado: (2022)

Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats
por: Hattori, Mai, et al.
Publicado: (2022)

Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect
por: Ichikawa, Shuichi, et al.
Publicado: (2022)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020)

A Patient with Bilateral Primary Aldosteronism Refractory to Oral Eplerenone Who Responded to Esaxerenone with Increased Renin Activity
por: Okamura, Keisuke, et al.
Publicado: (2020)

Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension
por: Rakugi, Hiromi, et al.
Publicado: (2019)

Factors Associated with the Antihypertensive Effect of Esaxerenone and Serum Potassium Elevation: A Pooled Analysis of Seven Phase III Studies
por: Ito, Sadayoshi, et al.
Publicado: (2023)

SUN-176 A Case of Aldosterone-Producing Adenoma with Preoperative Use of a Novel Mineralocorticoid Receptor Antagonist Esaxerenone
por: Yamanami, Hiroaki
Publicado: (2020)

Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone
por: Qiang, Panpan, et al.
Publicado: (2022)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
por: Ide, Kana, et al.
Publicado: (2018)

Optical coherence tomography findings in three patients with Werner syndrome
por: Nagai, Tatsuya, et al.
Publicado: (2022)

Efficacy and safety of esaxerenone (CS-3150), a newly available nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with primary aldosteronism
por: Satoh, Fumitoshi, et al.
Publicado: (2020)

Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice
por: Gao, Xiaomeng, et al.
Publicado: (2023)

Werner syndrome: a model for sarcopenia due to accelerated aging
por: Yamaga, Masaya, et al.
Publicado: (2017)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
por: Jędrusik, Piotr, et al.
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
por: Arai, Sayaka, et al.
Publicado: (2019)

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023)

Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing’s disease: a case report
por: Takiguchi, Tomoko, et al.
Publicado: (2017)

Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
por: Kirigaya, Yoshiaki, et al.
Publicado: (2020)

MON-188 Characterization and Categorization Based on Genotype-Biochemical Phenotype Association in Fructose-1,6-Bisphosphatase Deficiency
por: Sakuma, Ikki, et al.
Publicado: (2019)

An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice
por: Koshizaka, Masaya, et al.
Publicado: (2012)

SAT-520 The Effects Of AKAP13 On Osteogenesis By Modulation Of RhoA And Wnt Signaling
por: Ishida, Akiko, et al.
Publicado: (2019)

A Selective Mineralocorticoid Receptor Blocker, Esaxerenone, Attenuates Vascular Dysfunction in Diabetic C57BL/6 Mice
por: Munkhjargal, Uugantsetseg, et al.
Publicado: (2023)

Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone
por: Rakugi, Hiromi, et al.
Publicado: (2020)

Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males
por: Toyama, Kaoru, et al.
Publicado: (2021)

Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes
por: Kario, Kazuomi, et al.
Publicado: (2021)

Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis
por: Shoji, Mayumi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pdooieqg8di0ihmdl8a3srm92p